A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma-Reference-Cited by-同舟云学术

A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma

Published:2016-03 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Shao Di,Lin Yongping,Liu Jilong,Wan Liang,Liu Zu,Cheng Shaomin,Fei Lingna,Deng Rongqing,Wang Jian,Chen Xi,Liu Liping,Gu Xia,Liang Wenhua,He Ping,Wang Jun,Ye Mingzhi,He Jianxing

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep22338.pdf

Reference24 articles.

1. Chen, W., Zheng, R., Zeng, H. & Zhang, S. Epidemiology of lung cancer in China. Thorac Cancer 6, 209–215 (2015).

2. Dienstmann, R., Rodon, J., Barretina, J. & Tabernero, J. Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges. J Clin Oncol 31, 1874–1884 (2013).

3. Aisner, D. & Marshall, C. Molecular Pathology of Non–Small Cell Lung Cancer. Am J Clin Pathol 138, 332–346 (2012).

4. Maemondo, M. et al. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR. N Engl J Med 362, 2380–2388 (2010).

5. Zhou, C. et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 12, 735–742 (2011).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma;Frontiers in Oncology;2024-05-13

2. Demystifying the Discussion of Sequencing Panel Size in Oncology Genetic Testing;European Medical Journal;2022-06-16

3. Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations;Cancer Research and Treatment;2022-01-15

4. Clinically relevant fusion oncogenes: detection and practical implications;Therapeutic Advances in Medical Oncology;2022-01

5. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients;Journal of Cancer Research and Clinical Oncology;2021-10-24